An observational study in Cancer and Malignant Neoplasm, sponsored by University of Texas Southwestern Medical Center. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by University of Texas Southwestern Medical Center · Observational
The goal of this study is to learn how common medical decisions made during routine care-such as medications, exercise recommendations, referrals, and imaging-affect health outcomes.
This is a prospective study designed to enable systematic evaluation of real-world interventions in cancer survivor clinics at UT Southwestern Medical Center. The registry will collect longitudinal clinical data and support pragmatic clinical decision-making based on available evidence and expert opinion. Pragmatic interventions may include variations in routine clinical care such as:
9,610 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 202 across 1,742 observational studies indexed under Neoplasms.
Browse Neoplasms studies →University of Texas Southwestern Medical Center is the lead sponsor of 1,009 studies on the registry; 201 are open to participants now.
Of its 138 completed or terminated interventional studies of FDA-regulated products, 105 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Study population includes participants that have a diagnosis of any malignant neoplasm and were treated at UTSW Comprehensive Cancer Center cancer clinics, cardio-oncology, or exercise oncology clinics. Receiving care in a participating UTSW cancer clinic or referred to these clinics.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This registry will support observational comparative effectiveness analyses of pragmatic clinical decisions. Clinical care decisions, including medication use, referral patterns, exercise recommendations, and imaging strategies, will be made by treating clinicians independent of study participation. No investigational drug or device is being tested.
Adverse Event occurrence
Occurrence of any grade 2+ adverse event (heart failure, etc.) following cancer diagnosis, as identified through structured data.
Time frame: From time of consent up to 12 months
Change in cardiovascular risk factors
To characterize the incidence, timing, and spectrum of cardiovascular events among cancer survivors. To evaluate associations between pragmatic interventions used in routine care and clinical outcomes
Time frame: From time of consent up to 12 months
No study locations are listed for this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Texas Southwestern Medical Center →